A genetic Guide to Psychological Treatment.

$25.00

Watch Full Video

Description

Over 23% of North Americans are pharmacologically medicated for a mood disorder, yet 40% of these people do not respond their treatment. Furthermore, 86% of people on
mood stabilizers report at least one major side effect. Why are these statistics so high?

Because we are still treating the underlying cause as abnormal hormone or neurotransmitter levels. Unfortunately, that is most frequently not the case. A patient may produce adequate levels of a neurotransmitter but not transport it to the receptor; or once it reaches the receptor it is unable to bind due to a receptor mutation. In these cases, hormone augmentation does not work and in fact, can often lead to adverse side effects. There is also a great deal of cross-over in symptomatology between neurotransmitter dysfunction and altered levels of cortisol, adrenaline, serotonin, dopamine, GABA and glutamate. So how do you know which neurotransmitter you need to balance, how to effectively get it to the receptor and when to account for alterations in chemicals such as cortisol? Looking at our genetics is the answer. In this lecture we will take a deep dive into all the various genes that help us determine which neurochemical pathway is imbalanced and how best to treat it. Comparative case studies will also be presented.